Cornell Pochily Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
Cornell Pochily Investment Advisors's XBI Position: Q2 2026 in Review
Cornell Pochily Investment Advisors opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 1,574 shares worth $249K. The stake represents 0.07% of the portfolio and ranks #168 among its holdings. This is a return to the name: Cornell Pochily Investment Advisors previously reported a position in XBI as recently as Q4 2025.
Cornell Pochily Investment Advisors first reported a position in XBI in Q1 2019 and has held it in 16 quarters since. The position peaked at $316K in Q4 2020. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Cornell Pochily Investment Advisors held 1,574 shares of State Street SPDR S&P Biotech ETF worth $249K as of Q2 2026.
- State Street SPDR S&P Biotech ETF was a new Cornell Pochily Investment Advisors position in Q2 2026.
- State Street SPDR S&P Biotech ETF made up 0.07% of Cornell Pochily Investment Advisors's portfolio in Q2 2026, its #168 holding.
- Cornell Pochily Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and has held it in 16 quarters since.
- Cornell Pochily Investment Advisors's State Street SPDR S&P Biotech ETF position peaked at $316K in Q4 2020.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Cornell Pochily Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.